HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2nd line antiretroviral regimen

Janin Nouhin; Sopheak Ngin; Sreymom Ken; Vara Ouk; Olivier Segeral; Kimlay Chea; Kerya Phon; Jean-Fran?ois Delfraissy; Eric Nerrienet

首页> 外文期刊>BMC proceedings. >HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2nd line antiretroviral regimen

【24h】

HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2nd line antiretroviral regimen

机译：失败的基于LPV的二线抗逆转录病毒疗法的柬埔寨感染HIV的患者中HIV-1 CRF 01_AE蛋白酶和整合编码区的HIV耐药性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《BMC proceedings.》 |2011年第s1期|共页
作者
Janin Nouhin; Sopheak Ngin; Sreymom Ken; Vara Ouk; Olivier Segeral; Kimlay Chea; Kerya Phon; Jean-Fran?ois Delfraissy; Eric Nerrienet;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy [J] . Merit Pauskar, Kristi Huik, Radko Avi, BMC Infectious Diseases . 2014,第SUPPLEMENTa4期

机译：抗逆转录病毒（ARV）治疗失败的HIV-1 CRF06_cpx感染患者的抗逆转录病毒药物耐药性和病毒嗜性
2. A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-na?ve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial [J] . Collins C. Iwuji, Duncan Churchill, Stephen Bremner, BMC Infectious Diseases . 2020,第1期

机译：IV阶段随机开放标签试验研究，以评估从基于蛋白酶抑制剂的方案转换为Bictegravir / Emtrickabine / Tenofovir alafenainide单片中的整体酶抑制剂-Na've，病毒学抑制的HIV-1感染的成年人患有耐药性突变（Pibik研究）：随机试验的研究方案
3. Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains [J] . Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases . 2020,第期

机译：为所有商业上可获得的逆转录酶，蛋白酶和整合酶抑制剂的开发新的综合HIV-1基因型耐药性测定，所述患者M HIV-1菌株患者
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Characterization of HIV-1 Integrase Strand Transfer Inhibitor (INSTI)-Enzyme Interactions Towards Long- Term Strategies to Suppress Viremia, Mitigate Antiretroviral Resistance and Prevent Transmission at a Population-Level [D] . ?Osman, Nathan 2020

机译：HIV-1整合酶链转移抑制剂（Insti） - 酶相互作用对抑制病毒血症的长期策略，减轻抗逆转录病毒抗性，防止人口水平传播
6. HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2nd line antiretroviral regimen [O] . Janin Nouhin, Sopheak Ngin, Sreymom Ken, 2011

机译：在基于LPV的二线抗逆转录病毒疗法失败的HIV感染的柬埔寨患者中HIV-1 CRF 01_AE蛋白酶和整合编码区的HIV耐药性
7. HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2nd line antiretroviral regimen [O] . Janin Nouhin, Sopheak Ngin, Sreymom Ken, 2011

机译：在基于LPV的二线抗逆转录病毒疗法失败的HIV感染的柬埔寨患者中，HIV-1 CRF 01_AE蛋白酶和整合编码区的HIV耐药性

HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2nd line antiretroviral regimen

著录项

相似文献

相关主题

期刊订阅